Renescience A/S: Financial statements 2020
CVR: 31846803
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Renescience A/S (CVR 31846803) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,692,000 and a net result of DKK -13,492,000 compared with DKK -18,126,000 the year before. The profit margin was -797.4%. Equity in the 2020 report amounted to DKK 31,076,000. The solvency ratio was 89.3%.
- Revenue
- DKK 1,692,000
- Gross Profit
- DKK -16,589,000
- Profit/Loss
- DKK -13,492,000
- Equity
- DKK 31,076,000
- Total Assets
- DKK 34,789,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
| 2019 | - | -23.2 mio. | -18.1 mio. | 44.6 mio. | - |
| 2018 | - | -24.3 mio. | -19.1 mio. | 62.7 mio. | - |
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
Official annual report
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Renescience A/S has published its annual report for 2019. Gross profit came to DKK -23,169,000, and the net result was DKK -18,126,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.